Ireland· IE-PA-EU/1/21/1595/001-002
ASPAVELI 1 080 mg solution for infusion
A pegcetacoplan product containing pegcetacoplan, registered in Ireland by Apellis Ireland Limited.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Pegcetacoplan
- Manufacturer
- Apellis Ireland Limited
- Country
- Ireland (IE)
- ATC code
- L04AA54
- ATC class
- Pegcetacoplan
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1595/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pegcetacoplan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEmpaveliApellis Pharmaceuticals, Inc.
- CzechiaASPAVELISwedish Orphan Biovitrum AB (publ), Stockholm
- SwitzerlandAspaveli
- FinlandASPAVELISwedish Orphan Biovitrum AB (publ)
- FranceASPAVELI 1080 mg, solution pour perfusionSWEDISH ORPHAN BIOVITRUM (SUEDE)
- BelgiumAspaveli 1080 mgSwedish Orphan Biovitrum (Publ)
- IcelandASPAVELI*Swedish Orphan Biovitrum AB (publ)
- NetherlandsAspaveli 1080 mg oplossing voor infusieApellis Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aspaveli
- Liechtenstein · Aspaveli
- Norway · Aspaveli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aad06ef3-9a9b-4685-948f-48ef2d404bf4 GET /v1/drugs/aad06ef3-9a9b-4685-948f-48ef2d404bf4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"L04AA54"
],
"strength": null,
"pa_number": "EU/1/21/1595/001-002",
"substances": [
"Pegcetacoplan"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "13/12/2021",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pegcetacoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.